On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

A urticaria rash can either be a nonimmune response to ... risk factors, symptoms, and treatment. Contact urticaria is an immediate and short lived reaction to a certain substance, with symptoms ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

A doctor has shed some light on why itchy rashes sometimes mysteriously appear on the body - and what you need to do ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

If your child has a rash accompanied by feverish symptoms, don't hesitate to get an urgent GP appointment. Hives usually clear up soon enough, with home treatment sufficing in many cases ...

As spring transitions into summer in Southern Nevada, bee activity increases significantly, creating both ecological benefits and potential challenges for residents. Understanding how to safely manage ...

Here's how to tell whether your child is having a serious reaction to a shot, what symptoms to watch for, and when to call ...